Funding profile · AI emergency neuroimaging

Caire Health

No Form D has been filed under Caire Health’s name, and the only funding figure on record is a $125,000 Y Combinator seed check from 2021. Here is what little the capital picture shows, and where the sources disagree with each other.

$125KSeed funding, Sep 2021, reported by Dealroom and Tracxn
$0Funding reported by a separate estimator, GetLatka
$330KEstimated 2025 revenue, GetLatka estimate, not disclosed by the company
0Form D filings found under Caire Health, Inc. or a similar name

Data as of September 22, 2026. Company-reported and estimated figures are labeled.

Rounds at a glance

When Round Amount Investors Source
Sep 2021 Seed, tied to Y Combinator Summer 2021 $125,000 Y Combinator; Tracxn lists 2 institutional investors, not individually named Aggregator
2021 to 2026 No further round found None disclosed None found Not found

What the filings show

Nothing. A search of SEC EDGAR for Caire Health, Inc. and close variants returns no Form D notice. One filer with an adjacent name, Caire Health Holdings, Inc. (CIK 0001964926, formerly Caire Holdings, Inc.), filed a Form D on February 10, 2023 reporting an $18.1 million offering with $6.66 million sold from 2 investors. Its related persons are John Beadle, Thomas Manning, Zachary Tan, Kathleen O’Donnell, Laurence Kraemer and Sijia Yu, all listed at a New York address. Public reporting ties John Beadle to Aegis Ventures and identifies that entity’s “Caire” as a separate virtual care platform launched with Northwell Holdings, not to the Warman brothers’ head CT company. That filing is excluded from the figures above because it cannot be tied to this company.

Reading the record

  1. The only number on file is small and old.Dealroom and Tracxn both put total funding at $125,000, dated to the company’s Y Combinator Summer 2021 batch. Neither aggregator lists a lead investor or names the “2 institutional investors” Tracxn references, and no press release describing the round was found.
  2. One estimator shows nothing at all.GetLatka’s company page lists $0 in reported funding and states plainly that it has no funding information for Caire Health, directly contradicting the $125,000 figure elsewhere. Neither source is a primary filing, so the gap is unresolved.
  3. No Regulation D notice, and no clear reason why.A $125,000 friends-and-YC-scale check often falls under exemptions that do not require a Form D, or simply goes unfiled in practice by very early-stage companies. Absence of a filing here is consistent with the round’s reported size, not evidence that no money moved.
  4. A same-name filer is not this company.Caire Health Holdings, Inc., incorporated in Delaware in 2022 with a Manhattan address and a board that includes former SPAC and holding-company operator John Beadle, raised real institutional money via Form D in 2023. It is a virtual-care venture tied to Aegis Ventures and Northwell Holdings, sharing only a name with the AI radiology company this page covers.
  5. Revenue is an outside guess, not a disclosure.The $330,000 2025 figure comes from GetLatka’s own estimate model, explicitly marked as such. Caire Health has not published revenue, and no other source corroborates the number.

Commercial signals

Signal Detail Source type
Team size About 3 employees as of 2024, per GetLatka. Aggregator
Regulatory No FDA 510(k) or PMA found for Caire Health or Caire ICH. Not found
Industry listing Listed in the Medical Technology Enterprise Consortium (MTEC) life sciences directory as of Feb 2025; no MTEC-funded award found for the company. Independent
Customers None named. The company site and third-party profiles describe target buyers as hospitals and emergency departments in general terms only. Not found

What to watch

  • Any Form D filed under Caire Health, Inc. or a matching CIK.
  • A priced round large enough to require SEC disclosure.
  • Whether the company or a customer discloses actual revenue, replacing the current estimate.
  • Named hospital or health system customers.

The Caire Health story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • Illuminant Surgical: Shared investor: Company-Stated Fund. A projector on a boom arm that paints a patient’s scan onto their own skin while the surgeon works
  • Avro Life Science: Shared investor: Company-Stated Fund. Two University of Waterloo first years set out to put a generic allergy pill into a sticker
  • Joon Health: Shared investor: Company-Stated Fund. A gamified app that turns a child’s ADHD, autism or anxiety routines into quests for a virtual pet
  • Egress Health: Shared investor: Company-Stated Fund. AI agents built to chase down what dental practices are owed by insurance companies, starting with eligibility checks, claims and denials

Sources

  1. Public recordForm D, Caire Health Holdings, Inc. (unrelated entity, CIK 0001964926)SEC EDGAR · Feb 10, 2023
  2. AggregatorCaire Health company profile and fundingDealroom.co · accessed Sep 22, 2026
  3. AggregatorCaire Health company profile and fundingTracxn · accessed Sep 22, 2026
  4. AggregatorCaire Health revenue and team estimateGetLatka · accessed Sep 22, 2026
  5. IndependentAegis Ventures and Northwell Holdings tap former Mayo CEO as executive chairman of virtual care platform CairePR Newswire · accessed Sep 22, 2026
  6. IndependentHere are all the companies from Y Combinator’s Summer 2021 demo day, part 1TechCrunch · Aug 31, 2021
  7. CompanyCaire Health profileMedical Technology Enterprise Consortium (MTEC) · Feb 13, 2025
  8. CompanyCaire Health, Semi-Autonomous Diagnostics for Emergent CareY Combinator company page · accessed Sep 22, 2026

Compiled from SEC and other public records and published reports as of September 22, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date. Healthcare Venture Capital Fund holds no position in Caire Health. This page is not an offer to sell or a recommendation to buy any security.